“Age Reversal Is Coming.” Inside The First Human Trials - Dr David Sinclair - #1141

Dr. David Sinclair, a leading voice in longevity research, reflects on his journey since their first podcast in 2019. He shares exciting developments in gene therapy, particularly the success of Yamanaka factors in reversing aging in animals and the hopeful transition to human trials for eye diseases. Sinclair discusses the monumental impact of AI, which allows researchers to analyze vast data quickly and reveal potential drug candidates. He explains the significance of lifestyle choices, such as weight management and social connections, on longevity, advocating for a balanced approach involving diet, exercise, and mental well-being. Sinclair also evaluates common interventions like creatine, glucose monitors, and the use of GLP-1 drugs for weight management, suggesting they may have additional benefits for longevity. He reinforces the importance of a positive mental attitude and self-experimentation while cautioning against the dangers of over-optimizing health routines. Finally, Sinclair expresses enthusiasm about the future of longevity science and invites listeners to join the community at lifespan.com for ongoing developments and resources.